MedTrace Logo

The Impact of Cytochrome P450 Abnormalities in Patients With Delirium.

NCT03829670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-10-04

No results posted yet for this study

Summary

Objectives:

1. To examine whether patients with delirium have higher prevalence of cytochrome-P450 abnormalities compared to patients without delirium.
2. To examine whether the severity of delirium is related to a specific cytochrome P450 genotype.
3. To examine the persistence of delirium at 6-8 weeks stratified by presence of cytochrome p450 abnormalities
4. To examine whether delirium persistence is impacted by types of medications administered during their hospital stay.

Conditions

  • Delirium, Cytochrome P-450 Enzyme System

Interventions

DIAGNOSTIC_TEST

Cytochrome P450 test

Blood samples will be drawn for cytochrome P450 testing.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • David Ronin, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2020-06-24
Completion
2020-06-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03829670 on ClinicalTrials.gov